Skip to content

Calculus invests in Spectral MD

Calculus VCT has invested £0.5m into Spectral MD through an oversubscribed inital public offering onto AIM, on Tuesday 22 June. The Dallas-based firm, which is building notable presence in the UK as part of its product launch effort, produces predictive analytics, proprietary AI algorithms and imaging systems to assist with medical treatment. Spectral MD’s technology, … Continued

Phase 1 clinical trial planned for Scancell’s novel bivalent COVID-19 vaccine

22 June 2021 – Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, today announces an update on COVIDITY clinical trial plans and the publication of preclinical data on two vaccine candidates from its COVIDITY research programme. The COVIDITY programme is a collaboration between Scancell and … Continued

Calculus invests in Arecor following successful IPO

Arecor announced its admission to trading on AIM, a market operated by London Stock Exchange, on 3 June 2021. Admission follows a successful oversubscribed placing by Panmure Gordon, raising gross proceeds of £20 million at a price of 226 pence per share. On Admission the Company will have a market capitalisation of approximately £62.5 million. … Continued

Calculus VCT – 2% off the initial fee – limited time only

– 2% off the initial fee until 29 June, apply before this date to receive the summer 2021 dividend  – Target annual tax free dividend of 4.5% of NAV – Portfolio of entrepreneurial, growth orientated companies across technology, healthcare and creative industries. See portfolio company examples here – Dividend Reinvestment Scheme and monthly standing order available – … Continued

Calculus Exits Sports Tour Operator inspiresport

inspiresport is the industry leading sports development tour operator, offering unrivaled access to world class clubs, coaches, and facilities to take young players of all abilities on extraordinary sporting journeys. The company has been acquired by Portman Travel Group, which is expanding into the sports travel market, providing an exit event for Calculus investors. Calculus, … Continued